← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

autologous anti-MART-1 F5 T-cell receptor (autologous anti-MART-1 F5 T-cell receptor)

Melanoma; Skin Cancer · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes (autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes)

Melanoma · Metastatic Melanoma

#MetastaticMelanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 DISCONTINUED
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, disitamab vedotin, sintilimab, capecitabine)

Rectal Cancer · Rectal Cancer

#RectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
CGTBiologicstaleTmunity Therapeutics, a wholly …Phase 1

huCART-meso cells (huCART-meso cells)

Lung Adenocarcinoma; Ovarian Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0%임상시험 3상태 DISCONTINUED
AntibodystaleMacroGenicsPhase 3

margetuximab (margetuximab)

Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 62.5%임상시험 3상태 ACTIVE
AntibodystaleRochePhase 3

pertuzumab (Perjeta, pertuzumab [Perjeta])

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 7.1%임상시험 3상태 ACTIVE
ADCBiologicstaleMacroGenicsPhase 2

vobramitamab duocarmazine (vobramitamab duocarmazine)

Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 45.8%임상시험 3상태 DISCONTINUED
AntibodystaleDavid HoPhase 1

10E8.4/iMab (10E8.4/iMab)

HIV-1-infection · HIV-1-infection

#HIV-1-infection#Antibody#Phase1#항체#면역항체+2
임상시험 2상태 ACTIVE
CGTBiologicMedical College of WisconsinPhase 2

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

Non Hodgkin Lymphoma (NHL); Mantle Cell Lymphoma (MCL) · Non Hodgkin Lymphoma (NHL)

#NonHodgkinLymphomaNHL#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

21.15.GPC3-CAR T cells (21.15.GPC3-CAR T cells)

Atypical Teratoid Rhabdoid Tumor; Central Nervous System Rhabdoid Tumor · Hepatoblastoma

#Hepatoblastoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
ADCBiologicstaleRobert Flavell, MD, PhDPhase 1

89Zr-DFO-YS5 (89Zr-DFO-YS5)

Prostate Cancer; Metastatic Castration-resistant Prostate Cancer · Prostate Cancer

#ProstateCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, 89Zr-DFO-daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
CGTAAVBiologicstaleAdrenas Therapeutics IncPhase 2

AAV BBP-631 (AAV BBP-631)

Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia

#CongenitalAdrenalHyperplasia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 2상태 RECRUITING
CGTAAVBiologicstaleNational Human Genome Research …Phase 2

AAV9-GLB1 (AAV9-GLB1)

Lysosomal Diseases; Gangliosidosis · Lysosomal Diseases

#LysosomalDiseases#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
ADCBiologicstaleAbbViePhase 1

ABBV-838 (ABBV-838)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 DISCONTINUED
ADCBiologicstaleNew York Medical CollegePhase 2

AD CP (AD CP)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 1%임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, AMG 386 and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
ADCBiologicMultitude Therapeutics Inc.Phase 2

AMT-676 (AMT-676)

Colorectal Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstalePeking Union Medical CollegePhase 2

AR,AR antagonist +goserelin +docetaxel (AR,AR antagonist +goserelin +docetaxel)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

ARV-471 + Abemaciclib (ARV-471 + Abemaciclib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING

63 / 209 페이지

← 이전다음 →